DSKYF

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF)

About DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF)

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Details

Daily high

$23.34

Daily low

$21.50

Price at open

52 Week High

$44.64

52 Week Low

$19.85

Market cap

39.8B

Dividend yield

1.90%

Volume

20,000

Avg. volume

17,754

P/E ratio

21.00

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. News